Ambroxol Andromaco indications
For use Max Pidek Pharmaceuticals as monotherapy and in combination with clavulanic acid: an infectious-inflammatory diseases caused by susceptible microorganisms, including bronchitis, pneumonia, tonsillitis, pyelonephritis, urethritis, infections of the gastrointestinal tract, gynecological infections, infections of the skin and soft tissue, listeria, leptospirosis, gonorrhea.
For use Max Pidek Pharmaceuticals in combination with metronidazole: chronic gastritis in acute, peptic ulcer and duodenal ulcer in acute, associated with Helicobacter Pylori.
Uses of Ambroxol Andromaco in details
Ambroxol Andromaco is used to treat certain diseases of the respiratory tract and to relieve cough associated with thickened mucous.
Ambroxol Andromaco description
Each retard capsule contains Ambroxol hydrochloride 75 mg.
Each tablet contains Ambroxol hydrochloride 30 mg.
Each 5 mL of syrup contains Ambroxol hydrochloride 15 or 30 mg.
Each mL of syrup (infant drops) contains Ambroxol hydrochloride 6 mg.
Ambroxol Andromaco hydrochloride is trans-4-[(2-amino-3,5-dibromo-benzyl)amino] cyclohexanol hydrochloride.
It also contains the following excipients: Retard Capsules: Crospovidone collidon CL, carnauba wax, stearyl alcohol, magnesium stearate.
Tablets: Lactose, maize starch, colloidal silica, magnesium stearate.
Syrup: Purified water, sorbitol liquid, glycerol 85%, woodberry aroma (15 mg only), strawberry aroma (30 mg only), hydroxyethylcellulose, benzoic acid, acesulfame potassium, vanilla aroma.
Infant Drops: Hydroxyethylcellulose, sorbitol solution, glycerol 85%, sodium saccharin, pharma flavors, menthol, benzoic acid, propylene glycol.
Ambroxol Andromaco dosage
Sustained-Release Capsule: Adults and Children >12 years: 1 cap once daily after meal with plenty of liquid (sufficient supply of liquid supports the expectorant effect of Ambroxol Andromaco).
Ambroxol Andromaco SR capsule is not suitable for children <12 years.
Tablet: Adults and Children >12 years: 1 tab thrice daily for the first 2-3 days and then 1 tab twice daily or ½ tab thrice daily. Children 6-12 years: ½ tab 2-3 times a day.
Syrup: Adults and Children >12 years: 10 mL thrice daily during the first 2-3 days, them 10 mL twice daily or 5 mL thrice daily. Children 6-12 years: 5 mL 2-3 times a day; 2-5 years: 2.5 mL 3 times a day; <2 years: 2.5 mL 2 times a day.
DS Syrup: Adults and Children >12 years: 5 mL thrice daily for 2-3 days then 5 mL twice daily for 2.5 mL thrice daily. Children 6-12 years: 2.5 mL 2-3 times a day.
Infant Drops: Children 13-24 months: 1.25 mL twice a day; 7-12 months: 1 mL twice a day; ≤6 months: 0.5 mL twice a day.
Ambroxol Andromaco interactions
Amoxicillin may decrease the effectiveness of contraceptives for oral administration.
With the simultaneous use of Max Pidek Pharmaceuticals with bactericidal antibiotics (including aminoglycosides, cephalosporins, cycloserine, vancomycin, rifampicin) appears synergies; with bacteriostatic antibiotic (including macrolides, chloramphenicol, lincosamides, tetracyclines, sulphonamide) - antagonism.
Amoxicillin increases the effects of indirect anticoagulants inhibiting intestinal microflora, reduces the synthesis of vitamin K and prothrombin index.
Amoxicillin reduces the effect of drugs, in the process of metabolism that produce PABA.
Probenecid, diuretics, allopurinol, phenylbutazone, NSAIDs decrease the tubular secretion of amoxicillin, which can be accompanied by an increase in its concentration in blood plasma.
Antacids, glucosamine, laxatives, aminoglycosides, slow down and reduce, and ascorbic acid increases the absorption of amoxicillin.
With the combined use of amoxicillin and clavulanic acid pharmacokinetics of both components unchanged.
Ambroxol Andromaco side effects
Allergic reactions: urticaria, erythema, edema Quincke, rhinitis, conjunctivitis, rarely - fever, joint pain, eosinophilia, in rare cases - anaphylactic shock.
Side effects associated with chemotherapy effect: possible development of super-infection (particularly in patients with chronic diseases or low resistance of the organism).
With prolonged use at high doses: dizziness, ataxia, confusion, depression, peripheral neuropathy, seizures.
Mostly when Max Pidek Pharmaceuticals used in combination with metronidazole: nausea, vomiting, anorexia, diarrhea, constipation, epigastric pain, glossitis, stomatitis; rarely - hepatitis, pseudomembranous colitis, allergic reactions (urticaria, angioedema), interstitial nephritis, a violation of hematopoiesis.
Mostly when Max Pidek Pharmaceuticals used in combination with clavulanic acid: cholestatic jaundice, hepatitis, rarely - erythema multiforme, toxic epidermal necrolysis, exfoliative dermatitis.
Ambroxol Andromaco contraindications
Hypersensitivity to Ambroxol Andromaco hydrochloride or to any other excipients of Ambroxol Andromaco.
In case of rare hereditary conditions that may be incompatible with an excipient of Ambroxol Andromaco, the use of Ambroxol Andromaco is contraindicated.
Active ingredient matches for Ambroxol Andromaco:
Ambroxol in Chile.
List of Ambroxol Andromaco substitutes (brand and generic names) | Sort by popularity |
Unit description / dosage (Manufacturer) | Price, USD |
Ambroxol-Teva 75 mg retard (Hungary) | |
Ambroxoli Hydrochloridi SIC (Georgia) | |
Ambroxoli hydrochloridum Berlin-Chemie (Poland) | |
Ambroxoli hydrochloridum Fontane (Poland) | |
Ambroxolium Chloride Berlin Chemie (Slovenia) | |
AMBROXOLIUMCHLORID FONTANE (Slovakia) | |
Ambroxolo Actavis (Italy) | |
Ambroxolo Almus (Italy) | |
Ambroxolo Angenerico (Italy) | |
Ambroxolo Dorom (Italy) | |
Ambroxolo Dr. Reddy's (Italy) | |
Ambroxolo EG (Italy) | |
Ambroxolo Germed (Italy) | |
Ambroxolo Hexal (Italy) | |
Ambroxolo Mylan (Italy) | |
Ambroxolo Mylan Generics (Italy) | |
Ambroxolo ratiopharm (Italy) | |
Ambroxolo Union Health (Italy) | |
Ambroxolum (Latvia) | |
Ambroxolum-ret. Stirol (Latvia) | |
Ambroxolvan (Brazil) | |
Ambroxomel (Brazil) | |
Ambryl (Bangladesh) | |
Ambryl 75 (Bangladesh) | |
Ambryl-SF (Bangladesh) | |
Amcold SYR (India) | |
Amcold SYR Cetirizine hydrochloride 5 mg, Ambroxol hydrochloride 30 mg. SYR / 100ml (Tablets) | $ 0.36 |
100ml (Tablets) | $ 0.36 |
AMCOLD SYR syr 100ml (Tablets) | $ 0.36 |
Amelex (Philippines) | |
Amelex 75 mg x 100's | |
Amgicol (Taiwan) | |
Amgicol 30 mg | |
Amgicol 30 mg x Blister pk | |
Amlee-P (India) | |
Amlee-P Ambroxol hydrochloride 60 mg, Levocetirizine dihydrochloride5 mg, Pseudoephedrinehydrochloride 30 mg. TAB / 100 (Indkus) | $ 6.51 |
100's (Indkus) | $ 6.51 |
AMLEE-P tab 10's (Indkus) | $ 0.65 |
Amobronc (Italy) | |
Amocol (Mexico) | |
Ampromed (Myanmar, Thailand, United States) | |
Ampromed 30 mg x 1, 000's (Millimed) | |
Amriz (India) | |
Amriz Ambroxol hydrochloride, Terbutaline sulphate, Guaiphenesin, Menthol. SYR / 100ml (Ritz Pharma) | $ 0.51 |
Amriz Ambroxol hydrochloride, Terbutaline sulphate, Guaiphenesin, Menthol. SYR / 60ml (Ritz Pharma) | $ 0.34 |
100ml (Ritz Pharma) | $ 0.51 |
60ml (Ritz Pharma) | $ 0.34 |
AMRIZ syr 100ml (Ritz Pharma) | $ 0.51 |
See 3105 substitutes for Ambroxol Andromaco |
References
- PubChem. "ambroxol". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- DrugBank. "ambroxol". http://www.drugbank.ca/drugs/DB06742 (accessed September 17, 2018).
- MeSH. "Expectorants". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Ambroxol Andromaco are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Ambroxol Andromaco. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported useful
No survey data has been collected yetConsumer reported price estimates
No survey data has been collected yetConsumer reported time for results
No survey data has been collected yetConsumer reported age
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology